Bing Wang

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease

O. Ibraghimov-Beskrovnaya, H. Husson, Chou-Long Huang, 2022, Scientific Reports.

Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with disease

Hyejung Park, J. Leonard, Leslie K. Cortes, 2022, PloS one.

A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease.

R. Barker, S. Sardi, Hyejung Park, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment

Tingting Shen, Bing Wang, Q. Yin, 2022, Frontiers in Pharmacology.

Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model

Can Kayatekin, S. Sardi, L. Shihabuddin, 2021, Scientific Reports.

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

J. Locascio, Ganqiang Liu, S. Sardi, 2021, NPJ Parkinson's disease.

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

J. Locascio, Ganqiang Liu, S. Sardi, 2021, npj Parkinson's Disease.

Notoginsenoside Fc ameliorates renal tubular injury and mitochondrial damage in acetaminophen-induced acute kidney injury partly by regulating SIRT3/SOD2 pathway

Miao-miao Wei, Wei Zhang, Niansong Wang, 2023, Frontiers in Medicine.